FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/12/2024
Back to search
Official data from USPTO
LEEZOVI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LEEZOVI
ST13
US500000079362721Class
1, 5, 42, 44
Filing
79362721
Registration
7215591
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
03/12/2024
Trademark type
Word
Nice classes
1, 5, 42, 44
Filing date
07/28/2022
Registration date
11/14/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/14/2023
Last transaction
11/14/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
LEIPZIG, MARC
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Miltenyi Biotec B.V. & Co. KG
Representatives
Michelle J. Levin Leason Ellis LLP
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalbiological and biochemical products for industrialscientificdiagnostic purposesbiological tissue culturesdiagnostic preparations for scientific use; Chemical preparations for use in separation processes for biological materials; reagents for scientific and research usereagents for cell separationlabeling reagentsreagents for the preparation of mediaall for commercial and scientific purposes and for the use in medical laboratories; chemical reagentsother than for medical or veterinary purposes with magnetic beads; chemical antibody reagentsother than for medical or veterinary purposes; buffer solutions for scientific purposes in analytical chemistry and chemical reagentsfor non-medical purposesfor use with laboratory instrumentsespecially separation instrumentschemical analysis instrumentsreactors and imaging instruments; reagentsother than for medical or veterinary purposesfor processing of biological materialespecially tissuebone marrowcellsblood; diagnostic reagents and preparations for scientific purposes and for use in medical laboratories; cell culture mediafor in-vivo imagingall for scientific purposes; chemical reagents for non-medical purposesfor use in biotechnologyin biological treatment processes and in the biotechnology industry
Class 5
Pharmaceutical preparations for use in treating cancer or autoimmune diseases; veterinary preparations for use in treating cancer or autoimmune diseases in household animals and horses; medicinal preparations for cancer or autoimmune diseases; Reagents and media for medical and veterinary diagnostic purposes; diagnostic reagents for medical use and veterinary diagnostic reagentsreagents containing magnetic beadsantibody reagents and reagents for the processingseparationisolationenrichmentdepletiondetectionscreeninganalysis and counting of materialespecially of biological materials; Reagents for medical use and clinical medical reagentsreagents for use with medical instrumentsespecially separation instrumentsanalysis instrumentsreactor and imaging instruments; reagents for the processing of biological materialespecially tissuebone marrowcellsblood and its componentsall for medical or veterinary purposes; Media for bacteriological cultures; diagnostic reagents and preparations for medical and veterinary purposes; contrast agents for in-vivo imagingall for medical and veterinary purposes; pharmaceutical preparations for cellular therapy
Class 42
Medicalpharmaceutical and biotechnological laboratory services; medical laboratory services and laboratory research services relating to pharmaceuticalsin particular in connection with the manufacture of cell therapeutic agentscell compoundscellular medicinesfeaturing the selectionstimulationactivation of cellsas well as the manufacture of medical and scientific kits and reagents
Class 44
Medical servicesin particular the field of extracorporeal plasma therapy; medical treatment servicesmedical treatment of cancer or autoimmune diseases
Publications
History of USPTO decisions and trademark events.
33 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/21/2024
FIMP
FINAL DISPOSITION PROCESSED
02/21/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/14/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/14/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
11/14/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/29/2023
PUBO
PUBLISHED FOR OPPOSITION
08/29/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/09/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/26/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/26/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/26/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/26/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/24/2023
GNRT
NON-FINAL ACTION E-MAILED
07/24/2023
CNRT
NON-FINAL ACTION WRITTEN
07/24/2023
RFNT
REFUSAL PROCESSED BY IB
07/22/2023
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
07/19/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/28/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
06/28/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/28/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/28/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/28/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/28/2023
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
06/24/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/21/2023
RFRR
REFUSAL PROCESSED BY MPU
06/21/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/17/2023
CNRT
NON-FINAL ACTION WRITTEN
05/16/2023
DOCK
ASSIGNED TO EXAMINER
05/16/2023
MAFR
APPLICATION FILING RECEIPT MAILED
02/21/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/17/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/16/2023
Continuous trademark protection
Get notified about every new filing that threatens LEEZOVI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.